J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 64 (1983), 1699-1704; DOI 10.1099/0022-1317-64-8-1699
© 1983 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grady, L. J.
Right arrow Articles by Deibel, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grady, L. J.
Right arrow Articles by Deibel, R.
Agricola
Right arrow Articles by Grady, L. J.
Right arrow Articles by Deibel, R.

Monoclonal Antibodies Against La Crosse Virus

L. J. Grady, S. Srihongse, M. A. Grayson and R. Deibel

Center for Laboratories and Research, New York State Department of Health, Albany, New York 12201, U.S.A.

Monoclonal antibodies have been used to show that an epitope is present on the G1 glycoprotein of prototype La Crosse virus that is absent or significantly altered on several isolates of La Crosse virus made in New York State, U.S.A. The portion of the G1 protein where this epitope is located plays a role in both virus neutralization and haemagglutination. Additional experiments revealed that under the appropriate assay conditions the monoclonal antibodies permitted discrimination between representatives of the North American members of the California serogroup.

Keywords: California serogroup viruses, La Crosse virus, monoclonal Abs

Received 8 February 1983; accepted 18 April 1983.


This article has been cited by other articles:


Home page
CVIHome page
N. Putkuri, A. Vaheri, and O. Vapalahti
Prevalence and Protein Specificity of Human Antibodies to Inkoo Virus Infection
Clin. Vaccine Immunol., December 1, 2007; 14(12): 1555 - 1562.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
A. Bertolotti-Ciarlet, J. Smith, K. Strecker, J. Paragas, L. A. Altamura, J. M. McFalls, N. Frias-Staheli, A. Garcia-Sastre, C. S. Schmaljohn, and R. W. Doms
Cellular Localization and Antigenic Characterization of Crimean-Congo Hemorrhagic Fever Virus Glycoproteins
J. Virol., May 15, 2005; 79(10): 6152 - 6161.
[Abstract] [Full Text] [PDF]


Home page
J. Gen. Virol.Home page
T.-Y. Kim, Y. Choi, H.-S. Cheong, and J. Choe
Identification of a cell surface 30 kDa protein as a candidate receptor for Hantaan virus
J. Gen. Virol., April 1, 2002; 83(4): 767 - 773.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
D. Sundin, B. Beaty, N Nathanson, and F Gonzalez-Scarano
A G1 glycoprotein epitope of La Crosse virus: a determinant of infection of Aedes triseriatus
Science, January 30, 1987; 235(4788): 591 - 593.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1983 by the Society for General Microbiology.